News Lilly adds another sales channel for obesity drug Zepbound Telehealth firm Ro will offer low-cost, single-dose vials of Lilly's obesity drug Zepbound, the first alternative to the new LillyDirect DTC channel.
News Bausch + Lomb dips on rumour of failing takeover talks Private equity group Blackstone is reported to be thinking of pulling out of a consortium to buy ophthalmology specialist Bausch + Lomb.
News ConTIPI starts rollout of pelvic organ prolapse device in US A non-invasive device that could help millions of women in the US with a condition known as pelvic organ prolapse (POP) has launched in the US.
News Suspect in UnitedHealth CEO killing charged with murder 26-year-old Luigi Mangione has been charged with murder and other offences following the murder of UnitedHealth CEO Brian Thompson last week.
News Novo’s $16.5bn Catalent deal cleared by EU Commission EU says Novo Holdings’ $16.5 billion takeover of US contract development and manufacturing organisation Catalent does not pose antitrust issues.
News Relief for Chinese biotechs as BIOSECURE Act delayed US legislation that could have a big impact on the businesses of five biotechs with links to China now looks unlikely to be passed this year.
Oncology ESMO26: Lowering toxicity, extending lives, with Syncromune As the ESMO26 Congress commences in Madrid, pharmaphorum invited Syncromune Executive Chairman Dr Chuck Link onto the podcast.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.